ELVN

ENLIVEN THERAPEUTICS INC

ELVN·29337E102·US·Common Stock·Healthcare - Biotechnology-Activist

ELVN (ENLIVEN THERAPEUTICS INC) is held by 91 institutional investors as of Q1 2026. Largest holders: FMR LLC ($267.7M), Polar Capital Holdings Plc ($198.6M), BlackRock, Inc. ($144.4M). Net institutional sentiment: Bullish.

91
Holders
Avg rating(18 Elite)
$1.1B
Total Value
75% (99)
Fund Consensus
70 buying - 23 selling
ELVNSmart Money Verdict
View all
Held by 91 funds
18 elite
Who's Trading
InsiderKAKunkel Lori AnneSell $205KJul 6, 2026
InsiderKAKunkel Lori AnneSell $299KJul 6, 2026
ActivistOAORBIMED ADVISORS LLC9.5%Jun 24, 2026
ActivistPolar Capital Holdings PlcPolar Capital Holdings Plc8.5%Jun 22, 2026
InsiderHBHohl BenjaminSell $59KJun 17, 2026
InsiderHBHohl BenjaminSell $149KJun 17, 2026
InsiderHBHohl BenjaminSell $55KJun 17, 2026
ActivistOAORBIMED ADVISORS LLC10.9%Jun 17, 2026
ActivistVHVenrock Healthcare Capital Partners III, L.P.2.8%May 15, 2026
ActivistFAFairmount Funds Management LLC3.1%May 15, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
6.8M(-3.9%)$267.7M0.0%+130.60%
0
Increased
5.1M(+44.2%)$198.6M0.7%+116.04%
58
Increased
3.7M(+2.0%)$144.4M0.0%+132.09%
31
Increased
1.7M(+22.4%)$68.4M0.0%+132.70%
36
Increased
1.1M(+3.6%)$42.8M0.0%+180.25%
30
Increased
1.1M(+1.7%)$41.8M0.0%+145.70%
30
Decreased
929,544(-28.7%)$36.4M0.0%+128.48%
0
Increased
905,191(+233.5%)$35.5M0.2%+103.94%
56
Increased
681,715(+70.9%)$26.7M0.0%+130.44%
43
Increased
594,079(+31.1%)$23.3M0.1%+127.02%
43
Increased
518,572(+25.9%)$20.3M0.0%+139.84%
35
Increased
473,115(+99.5%)$18.5M0.0%+103.64%
46
Increased
372,316(+5.7%)$14.6M0.0%+145.07%
30
New
370,000$14.5M0.1%+77.70%
39
Increased
360,577(+1.5%)$14.1M0.0%+161.98%
28
Increased
345,318(+16.3%)$13.5M0.0%+130.97%
32
New
310,025$12.2M0.0%+77.70%
39
New
309,180$12.1M0.0%+77.70%
39
Increased
771,885(+1995.2%)$11.9M0.0%+80.55%
45
Increased
301,673(+0.2%)$11.8M0.0%+165.63%
28

Showing 1-20 of 99

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used